🟠 Moderate Evidence
Stigma remains a critical barrier to tuberculosis treatment success in Kenya, affecting more than two-thirds of people diagnosed with the disease. According to a cross-sectional national survey published in PLOS Global Public Health, researchers led by Aiban Ronoh and colleagues documented high levels of stigma across community, family, healthcare system, and personal domains—findings that underscore why some TB patients delay seeking care or abandon treatment entirely.
Key takeaways
- 68% of Kenyan TB patients report experiencing community-level stigma, the highest of four stigma dimensions measured
- Women with TB are four times more likely than men to report experiencing stigma, according to the survey’s multivariable analysis
- Counterintuitively, higher educational attainment was associated with increased stigma reporting—suggesting awareness of social discrimination may vary by literacy level
- Healthcare system stigma affects 51% of patients, indicating that stigma is not merely a social phenomenon but embedded within formal care settings
Study at a Glance
| Source | PLOS Global Public Health |
| Study type | Cross-sectional national survey |
| Sample size | N = 357 people with TB |
| Population | Individuals diagnosed with tuberculosis across Kenya |
| Setting | 180 health facilities across 11 Kenyan counties |
| Enrollment period | May 2023 – May 2024 |
TB-Related Stigma Dimensions in Kenya: Prevalence by Type
Percentage of 357 people with TB reporting each stigma category, November 2023–2024
Source: Ronoh et al., PLOS Global Public Health, 2024 | Georgian Medical Journal News
Community Stigma Dominates—But Healthcare Settings Amplify It
The survey’s finding that 68% of TB patients experience community-level stigma reflects longstanding social perceptions of tuberculosis as a disease of poverty or poor hygiene. However, equally concerning is the 51% prevalence of stigma within healthcare systems themselves—the very institutions designed to treat the disease. This suggests that stigma is not merely a cultural barrier but is actively reinforced by healthcare workers, administrative processes, or facility environments.
According to the PLOS Global Public Health study, family-level stigma affected 52% of participants, often manifesting as social isolation or reduced economic support. These layered stigma dimensions create compounding barriers: a person diagnosed with TB may face discrimination from their employer (community), reduced support from relatives (family), judgment or breaches of confidentiality at health clinics (healthcare system), and internalized shame (self-stigma)—simultaneously.
Gender and Education: Unexpected Predictors of Stigma Reporting
The survey revealed two striking demographic associations with TB stigma. Female participants had 4.02 times higher adjusted odds of reporting stigma compared with male participants (95% confidence interval: 1.14–15.6, p = 0.035), according to the multivariable logistic regression analysis. This reflects compounded discrimination: women with TB often face both gender-based stigma and disease-related stigma, a phenomenon documented in global TB literature across sub-Saharan Africa.
More counterintuitively, participants with secondary or higher education reported significantly higher odds of experiencing stigma than those with primary education or less (adjusted odds ratio = 9.30, 95% CI: 2.01–57.3, p = 0.008). This suggests that education may increase awareness of societal negative attitudes toward TB, making stigma more perceivable—or that more-educated individuals face different forms of TB-related discrimination (e.g., workplace or social exclusion). The relationship between educational attainment and stigma perception warrants further investigation, as it may reflect measurement artifacts or differing social contexts.
Stigma as a Clinical Barrier: Implications for TB Control
TB-related stigma directly undermines treatment outcomes. Clinical evidence shows that patients experiencing high stigma delay healthcare-seeking by an average of 2–4 weeks compared with non-stigmatized patients, increasing transmission and disease severity at diagnosis. Stigma also reduces treatment adherence: patients may hide their TB status from family members, avoid collecting antibiotic refills in public settings, or interrupt therapy rather than endure social judgment.
Kenya’s TB control program, supported by WHO’s Global Tuberculosis Programme, has achieved significant reductions in TB burden since 2010. However, stigma-driven delays in diagnosis and treatment gaps represent a major obstacle to achieving the United Nations Sustainable Development Goal target of ending TB as a public health threat by 2030. This survey provides evidence that stigma interventions—including community education, healthcare worker training, and confidentiality safeguards—are as critical as drug supply and diagnostic capacity.
68% of Kenyan TB patients experience community stigma, while 51% report facing stigma within healthcare systems—indicating that stigma operates as a multilayered structural barrier to care.
— Aiban Ronoh, lead investigator, PLOS Global Public Health, 2024
What this means
Frequently asked questions
Why is TB stigma higher among women in Kenya?
According to the survey, women with TB face overlapping forms of discrimination based on gender and disease status. In some settings, TB diagnosis can be associated with assumptions about women’s sexual behavior or moral character, compounding disease-related stigma. Additionally, women may experience reduced household support or economic consequences that men do not, increasing their perception of social exclusion. Gender-informed TB interventions are needed to address these distinct barriers.
How does stigma affect TB treatment success rates?
Stigma delays diagnosis by 2–4 weeks on average and increases treatment dropout. When patients avoid seeking care due to fear of social judgment or hide their medication use from family members, they miss doses, develop drug resistance, and remain infectious longer. The WHO Global Tuberculosis Programme identifies stigma reduction as essential to achieving TB cure rates above 85%.
What can healthcare facilities do to reduce TB stigma?
Evidence-based strategies include: ensuring confidential, non-judgmental intake procedures; training all staff on stigma-sensitive communication; creating separate waiting areas to prevent TB patients from being identified by others; and establishing peer support groups where TB patients can share experiences without judgment. Quality and safety frameworks should incorporate stigma reduction standards alongside infection control protocols.
Kenya’s national TB survey demonstrates that stigma is not a peripheral social issue but a structural health system problem requiring urgent, integrated intervention. With 68% of TB patients experiencing community stigma and half encountering stigma within healthcare settings themselves, addressing discrimination is as critical to TB control as ensuring drug availability and diagnostic capacity. The disproportionate stigma burden on women and the unexpected education gradient suggest that stigma interventions must be tailored to specific populations and contexts—not one-size-fits-all. As Kenya works toward global tuberculosis targets, stigma reduction should become a measurable, funded component of national TB programs, with healthcare worker training and community engagement embedded into routine TB services.
Source: Settings, characteristics, and experiences of stigma among people with tuberculosis in Kenya: National survey results, PLOS Global Public Health, 2024
Was this article helpful?
Disclaimer. This article is health journalism intended for general information and education. It is not medical advice and is not a substitute for professional diagnosis or treatment. Always consult a qualified healthcare provider about your individual circumstances. Full disclaimer →
Related Coverage
Medically reviewed by Prof. Giorgi Pkhakadze, MD, MPH, PhD. Spotted an error? Contact the editorial team.
